436 filings
Page 2 of 22
6-K
x2jr1ixl6d30ypf mqsg
3 Nov 23
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
8:26am
6-K
1vte9g9ladic8em
2 Nov 23
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
7:15am
6-K
w0x zq6s0r
20 Sep 23
Galapagos appoints Simon Sturge to its Board of Directors
6:00am
6-K
tyb50nxlfkyb32sn
30 Aug 23
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus
6:31am
6-K
7089ak
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
u4s60 02h4p2hw
15 Jun 23
Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating Officer
5:03pm
6-K
hfx0434awpa
13 Jun 23
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
7:53am
6-K
06z0wmgnct6eo3b3dcxe
12 Jun 23
Current report (foreign)
7:32am
SC 13G
7l7kew 4aot
7 Jun 23
GALAPAGOS / EcoR1 Capital ownership change
4:45pm
6-K
de0dspfs7pz43v88
25 May 23
Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositis
5:49pm
6-K
ehc1bmd
23 May 23
Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
7:30am
6-K
o2xt6ag09v
9 May 23
Galapagos creates new subscription right plans
5:02pm
6-K
mzgr86
5 May 23
Galapagos announces first quarter 2023 financial results
4:05pm
6-K
kszb7ji6
2 May 23
Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial Officer
4:49pm
6-K
tnknt m4no
2 May 23
Current report (foreign)
4:15pm
6-K
9xb6g zo8h7
26 Apr 23
Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting
8:23am
6-K
v14x54ez
25 Apr 23
Current report (foreign)
4:18pm
6-K
ky44a 5cwcrwzwq
31 Mar 23
Current report (foreign)
6:05am
6-K
fdho 5ypn3w5qu2q
27 Mar 23
Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting
5:05pm